Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

Carsten U Niemann; Mark-David Levin; Julie Dubois; Sabina Kersting; Lisbeth Enggaard; Gerrit J Veldhuis; Rogier Mous; Clemens H M Mellink; Johan A Dobber; Christian B Poulsen; Henrik Frederiksen; Ann Janssens; Ida Schjødt; Ellen C Dompeling; Juha Ranti; Mattias Mattsson; Mar Bellido; Hoa T T Tran; Kazem Nasserinejad; Arnon P Kater

doi:10.1182/blood.2020008608

Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

Carsten U Niemann, Mark-David Levin, Julie Dubois, Sabina Kersting, Lisbeth Enggaard, Gerrit J Veldhuis, Rogier Mous, Clemens H M Mellink, Johan A Dobber, Christian B Poulsen, Henrik Frederiksen, Ann Janssens, Ida Schjødt, Ellen C Dompeling, Juha Ranti, Mattias Mattsson, Mar Bellido, Hoa T T Tran, Kazem Nasserinejad, Arnon P Kater

Department of Haematology

24 Citations (Scopus)

Original language	English
Journal	Blood
Volume	137
Issue number	8
Pages (from-to)	1117-1120
Number of pages	4
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood.2020008608
Publication status	Published - 25 Feb 2021

Keywords

Adenine/analogs & derivatives
Adult
Aged
Aged, 80 and over
Antineoplastic Agents/therapeutic use
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Bridged Bicyclo Compounds, Heterocyclic/therapeutic use
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy
Male
Middle Aged
Neoplasm Recurrence, Local/drug therapy
Piperidines/therapeutic use
Protein Kinase Inhibitors/therapeutic use
Sulfonamides/therapeutic use
Treatment Outcome

Access to Document

10.1182/blood.2020008608

Cite this

Niemann, C. U., Levin, M.-D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Mattsson, M., Bellido, M., Tran, H. T. T., Nasserinejad, K., & Kater, A. P. (2021). Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia. Blood, 137(8), 1117-1120. https://doi.org/10.1182/blood.2020008608

Niemann, CU, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, GJ, Mous, R, Mellink, CHM, Dobber, JA, Poulsen, CB, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, EC, Ranti, J, Mattsson, M, Bellido, M, Tran, HTT, Nasserinejad, K & Kater, AP 2021, 'Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia', Blood, vol. 137, no. 8, pp. 1117-1120. https://doi.org/10.1182/blood.2020008608

@article{0e10a1e317544fd99991c533ffd345e3,

title = "Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia",

keywords = "Adenine/analogs & derivatives, Adult, Aged, Aged, 80 and over, Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Bridged Bicyclo Compounds, Heterocyclic/therapeutic use, Female, Humans, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Male, Middle Aged, Neoplasm Recurrence, Local/drug therapy, Piperidines/therapeutic use, Protein Kinase Inhibitors/therapeutic use, Sulfonamides/therapeutic use, Treatment Outcome",

author = "Niemann, {Carsten U} and Mark-David Levin and Julie Dubois and Sabina Kersting and Lisbeth Enggaard and Veldhuis, {Gerrit J} and Rogier Mous and Mellink, {Clemens H M} and Dobber, {Johan A} and Poulsen, {Christian B} and Henrik Frederiksen and Ann Janssens and Ida Schj{\o}dt and Dompeling, {Ellen C} and Juha Ranti and Mattias Mattsson and Mar Bellido and Tran, {Hoa T T} and Kazem Nasserinejad and Kater, {Arnon P}",

year = "2021",

month = feb,

day = "25",

doi = "10.1182/blood.2020008608",

language = "English",

volume = "137",

pages = "1117--1120",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "8",

}

TY - JOUR

T1 - Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

AU - Niemann, Carsten U

AU - Levin, Mark-David

AU - Dubois, Julie

AU - Kersting, Sabina

AU - Enggaard, Lisbeth

AU - Veldhuis, Gerrit J

AU - Mous, Rogier

AU - Mellink, Clemens H M

AU - Dobber, Johan A

AU - Poulsen, Christian B

AU - Frederiksen, Henrik

AU - Janssens, Ann

AU - Schjødt, Ida

AU - Dompeling, Ellen C

AU - Ranti, Juha

AU - Mattsson, Mattias

AU - Bellido, Mar

AU - Tran, Hoa T T

AU - Nasserinejad, Kazem

AU - Kater, Arnon P

PY - 2021/2/25

Y1 - 2021/2/25

KW - Adenine/analogs & derivatives

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Antineoplastic Agents/therapeutic use

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - Bridged Bicyclo Compounds, Heterocyclic/therapeutic use

KW - Female

KW - Humans

KW - Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy

KW - Male

KW - Middle Aged

KW - Neoplasm Recurrence, Local/drug therapy

KW - Piperidines/therapeutic use

KW - Protein Kinase Inhibitors/therapeutic use

KW - Sulfonamides/therapeutic use

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85100802986&partnerID=8YFLogxK

U2 - 10.1182/blood.2020008608

DO - 10.1182/blood.2020008608

M3 - Letter

C2 - 33027809

SN - 0006-4971

VL - 137

SP - 1117

EP - 1120

JO - Blood

JF - Blood

IS - 8

ER -

Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

Keywords

Access to Document

Other files and links

Cite this